GlassScriptPhysician profile
Amanda Diane Bitetti
NPI 1518620251
$4,575.95
in general payments reported to CMS, 2019-2025
18 companies · $1,563 in 2025
The $1,563 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $198 · 2023: $653 · 2024: $2,162 · 2025: $1,563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,813 · Travel and Lodging: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,812.62 |
| Travel and Lodging | $565.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,843.06 | 2023-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Alnylam Pharmaceuticals INC. | $405.96 | 2023-2025 | Amvuttra |
| Novartis Pharmaceuticals Corporation | $383.75 | 2022-2025 | |
| Bridgebio Pharma, INC. | $378.54 | 2025 | Attruby |
| E.R. Squibb & Sons, L.L.C. | $373.78 | 2022-2023 | Camzyos |
| Amgen INC. | $246.39 | 2023-2024 | Repatha |
| Merck Sharp & Dohme LLC | $209.53 | 2024-2025 | Verquvo, Winrevair, Capvaxive |
| Pfizer INC. | $150.62 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $146.88 | 2024-2025 | Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $79.01 | 2024 | Lifevest |
| Ancora Heart, INC. | $74.04 | 2024-2025 | Accucinch |
| Endotronix, INC. | $63.98 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Kestra Medical Technology Services, INC. | $53.91 | 2025 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $46.13 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $44.77 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $27.62 | 2025 | |
| Solventum Corporation | $25.95 | 2024 | Activ.A.C. |
| Kiniksa Pharmaceuticals, LTD. | $22.03 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Bitetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.